nexopamil has been researched along with Heart Disease, Ischemic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Braun, M; Hohlfeld, T; Schrör, K; Strobach, H | 1 |
Hutter, JJ; Nearing, BD; Verrier, RL | 1 |
2 other study(ies) available for nexopamil and Heart Disease, Ischemic
Article | Year |
---|---|
Protection of reperfused ischemic pig myocardium by nexopamil, a new combined Ca2+ and serotonin antagonist.
Topics: Animals; Blood Platelets; Calcium Channel Blockers; Creatine Kinase; Diastole; Epoprostenol; Female; Granulocytes; Heart; Hemodynamics; Male; Methoxamine; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Neutrophils; Serotonin Antagonists; Swine; Swine, Miniature; Thromboxane B2; Vasodilation; Verapamil | 1994 |
Potent antifibrillatory effect of combined blockade of calcium channels and 5-HT2 receptors with nexopamil during myocardial ischemia and reperfusion in dogs: comparison to diltiazem.
Topics: Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Coronary Circulation; Diltiazem; Dogs; Electrocardiography; Female; Hemodynamics; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Serotonin Antagonists; Verapamil | 1996 |